Chee Seong, Raymond Seet

Seet Chee Seong, Raymond

  • Associate Professor, Department of Medicine
  • Senior Consultant, Division of Neurology, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Research Programme Director, Division of Neurology, University Medicine Cluster, National University Health System
Academic Qualifications
  • MBBS, National University of Singapore, Singapore
  • MRCP, Royal College of Physicians, United Kingdom
  • MMed (Int Med), National University of Singapore, Singapore
  • FRCP, Royal College of Physicians of Edinburgh, United Kingdom
  • FAMS, Academy of Medicine, Singapore 
Research Interest(s)
  • Stroke Reperfusion Treatment
  • Neurocritical Care
  • Biomarkers
  • Atrial Fibrillation
  • Animal Stroke Model
  • Clinical Trials
Recent Publications
  • 1. Low SW, Teo K, Lwin S, Yeo LL, Paliwal PR, Ahmad A, Sinha AK, Teoh HL, Wong LY, Chong VF, Seet RC, Chan BP, Yeo TT, Chou N, Sharma VK2. 2015 Sep. Improvement in cerebral hemodynamic parameters and outcomes after superficial temporal artery-middle cerebral artery bypass in patients with severe stenoocclusive disease of the intracranial internal carotid or middle cerebral arteries. J Neurosurg. 123(3):662-9. doi: 10.3171/2014.11.JNS141553. 26023999.
  • 2. Lin L, Teng M, Zhao YJ, Khoo AL, Seet RC, Yong QW, Yeo TC, Lim BP. 2015 Apr. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly. Cardiovasc Drugs Ther. 29(2):187-97. doi: 10.1007/s10557-015-6584-7. 25860556.
  • 3. Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Ting E, Venketasubramanian N, Leow WK, Wakerley B, Kusama Y, Rathakrishnan R, Sharma VK. 2015 Feb. Assessment of intracranial collaterals on CT angiography in anterior circulation acute ischemic stroke. AJNR. AJNR Am J Neuroradiol. 36(2):289-94. doi: 10.3174/ajnr.A4117. 25324493.
  • 4. Dong Y, Koay WI, Yeo LL, Chen CL, Xu J, Seet RC, Lim EC. 2015. Rapid Screening for Cognitive Impairment in Parkinson's Disease: A Pilot Study. Parkinsons Dis. 2015:348063. doi: 10.1155/2015/348063. 26713170.
  • 5. Aulicky P, Rabinstein A, Seet RC, Neumann J, Mikulik R. 2013 Nov. Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcome. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. J Stroke Cerebrovasc Dis. 22(8):1293-7. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.010. 23246191.